Somatostatin analogue treatment for malignant hypercalcaemia

BMJ. 1990 May 19;300(6735):1313-4. doi: 10.1136/bmj.300.6735.1313-a.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenal Gland Neoplasms / complications
  • Dose-Response Relationship, Drug
  • Humans
  • Hypercalcemia / drug therapy*
  • Hypercalcemia / etiology
  • Male
  • Middle Aged
  • Octreotide / therapeutic use*
  • Pheochromocytoma / complications

Substances

  • Octreotide